نتایج جستجو برای: diffuse cutaneous scleroderma

تعداد نتایج: 124685  

2014
Ricardo Khouri Gilvaneia Silva Santos George Soares Jackson M. Costa Aldina Barral Manoel Barral-Netto Johan Van Weyenbergh

We show that increased plasma superoxide dismutase 1 (SOD1) levels are statistically significant predictors of the failure of pentavalent antimony treatment for cutaneous leishmaniasis caused by Leishmania braziliensis. In Leishmania amazonensis-infected patients, host SOD1 levels can be used to discriminate between localized and drug-resistant diffuse cutaneous leishmaniasis. Using in situ tra...

Journal: :AJNR. American journal of neuroradiology 2003
Mecit Kantarci Teoman Erdem Fatih Alper Cemal Gundogdu Adnan Okur Akin Aktas

We herein present the imaging findings in a case of diffuse primary cutaneous B-cell lymphoma of the cranial vault with orbital and brain invasion. MR imaging revealed first concomitant orbital and parenchymal invasion in a case of primary diffuse non-Hodgkin lymphoma of the cranial vault. Contrast-enhanced MR imaging revealed a diffuse mass in the scalp of the frontoparietal region bilaterally...

2011
Rachel Riera Luís EC Andrade Alexandre WS Souza Cristiane Kayser Edison T Yanagita Virgínia FM Trevisani

BACKGROUND Systemic sclerosis (scleroderma; SSc) is an orphan disease with the highest case-specific mortality of any connective-tissue disease. Excessive collagen deposit in affected tissues is a key for the disease's pathogenesis and comprises most of the clinical manifestations. Lidocaine seems to be an alternative treatment for scleroderma considering that: a) the patient's having excessive...

2012
Daniel P Hawley Eileen M Baildam Tania S Amin Mary K Cruikshank Joyce E Davidson Jennifer Dixon Neil S Martin Victoria Ohlsson Clarissa A Pilkington Satyapal Rangaraj Philip Riley Chitra Sundaramoorthy Jo Walsh Helen E Foster

Purpose Localised scleroderma (LS) and juvenile systemic sclerosis (jSSc) are very rare paediatric diseases managed by paediatric rheumatologists and dermatologists[1]. Optimal treatment is controversial in the absence of clinical trials, but most paediatric rheumatologists advocate systemic immunosuppression to avoid progressive deformity, functional disability and disfigurement[2]. We aimed t...

Journal: :Clinical and experimental rheumatology 2006
J E Gore A N Brown

Scleroderma renal crisis has been documented as the presenting manifestation of systemic sclerosis sine scleroderma in pregnancy only once in the literature. Unfortunately, since scleroderma renal crisis in sine scleroderma pregnant patients is so rare, that patient expired. We present a case of a sine scleroderma pregnant patient with an initial manifestation of scleroderma renal crisis surviv...

2016
Rucsandra Dobrota Britta Maurer Nicole Graf Suzana Jordan Carina Mihai Otylia Kowal-Bielecka Yannick Allanore Oliver Distler Tore K Kvien

Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland Department of Internal Medicine and Rheumatology, Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania Graf biostatistics, Winterthur, Switzerland Department of Rheumatology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland Department of Rheumatology, Universit...

2016
Jennifer D. Bahner Jeffrey F. Scott Pezhman Shoureshi Kord Honda Meg R. Gerstenblith

HSV: herpes simplex virus SCC: squamous cell carcinoma INTRODUCTION Metastatic disease to the skin can be difficult to diagnose clinically because it often mimics many infectious, inflammatory, and neoplastic skin conditions. Cutaneousmetastases can present as dermal or subcutaneous nodules, exophytic tumors resembling melanoma or nonmelanoma skin cancer, erythematous patches and plaques resemb...

Journal: :The Journal of rheumatology 2011
Murray Baron Marie Hudson Russell Steele Ernest Lo

OBJECTIVE The University of California at Los Angeles (UCLA) Scleroderma Clinical Trial Consortium GI Tract Instrument (UCLA SCTC GITI) was recently developed to measure gastrointestinal tract disease in systemic sclerosis (SSc). Our study assesses the internal consistency and validity of the instrument in a different population than was used in the original study. METHODS A sample of 113 con...

2011
Angela Ceribelli Malgorzata E Krzyszczak Yi Li Steven J Ross Jason YF Chan Edward KL Chan Rufus W Burlingame Tyler T Webb Michael R Bubb Eric S Sobel Westley H Reeves Minoru Satoh

INTRODUCTION Anti-RNA polymerase III (RNAP III) antibodies are highly specific markers of scleroderma (systemic sclerosis, SSc) and associated with a rapidly progressing subset of SSc. The clinical presentation of anti-RNAP III positive patients, onset of Raynaud's phenomenon (RP) and SSc in unselected patients in a rheumatology clinic were evaluated. METHODS Autoantibodies in sera from 1,966...

Journal: :Scandinavian journal of rheumatology 2013
H Ennis A Vail E Wragg A Taylor T Moore A Murray L Muir C E M Griffiths A L Herrick

OBJECTIVES Although digital ulcers (DUs) are common in patients with systemic sclerosis (SSc), prevalence estimates vary, and functional impact and pathophysiology have been relatively little studied. We investigated the point prevalence of all DUs (both digital-tip and extensor) in a cohort of patients with SSc, testing the hypothesis that both digital-tip and extensor ulcers are associated wi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید